Global Anti-GFP Antibody Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-GFP Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-GFP Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-GFP Antibody Market Perspective (2020-2031)
2.2 Global Anti-GFP Antibody Growth Trends by Region
2.2.1 Global Anti-GFP Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-GFP Antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-GFP Antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-GFP Antibody Market Dynamics
2.3.1 Anti-GFP Antibody Industry Trends
2.3.2 Anti-GFP Antibody Market Drivers
2.3.3 Anti-GFP Antibody Market Challenges
2.3.4 Anti-GFP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-GFP Antibody Players by Revenue
3.1.1 Global Top Anti-GFP Antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-GFP Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-GFP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-GFP Antibody Revenue
3.4 Global Anti-GFP Antibody Market Concentration Ratio
3.4.1 Global Anti-GFP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-GFP Antibody Revenue in 2024
3.5 Global Key Players of Anti-GFP Antibody Head office and Area Served
3.6 Global Key Players of Anti-GFP Antibody, Product and Application
3.7 Global Key Players of Anti-GFP Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-GFP Antibody Breakdown Data by Type
4.1 Global Anti-GFP Antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-GFP Antibody Forecasted Market Size by Type (2026-2031)
5 Anti-GFP Antibody Breakdown Data by Application
5.1 Global Anti-GFP Antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-GFP Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-GFP Antibody Market Size (2020-2031)
6.2 North America Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-GFP Antibody Market Size by Country (2020-2025)
6.4 North America Anti-GFP Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-GFP Antibody Market Size (2020-2031)
7.2 Europe Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-GFP Antibody Market Size by Country (2020-2025)
7.4 Europe Anti-GFP Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-GFP Antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-GFP Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-GFP Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-GFP Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-GFP Antibody Market Size (2020-2031)
9.2 Latin America Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-GFP Antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-GFP Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-GFP Antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-GFP Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-GFP Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-GFP Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Wako Chemicals
11.1.1 FUJIFILM Wako Chemicals Company Details
11.1.2 FUJIFILM Wako Chemicals Business Overview
11.1.3 FUJIFILM Wako Chemicals Anti-GFP Antibody Introduction
11.1.4 FUJIFILM Wako Chemicals Revenue in Anti-GFP Antibody Business (2020-2025)
11.1.5 FUJIFILM Wako Chemicals Recent Development
11.2 ProSci
11.2.1 ProSci Company Details
11.2.2 ProSci Business Overview
11.2.3 ProSci Anti-GFP Antibody Introduction
11.2.4 ProSci Revenue in Anti-GFP Antibody Business (2020-2025)
11.2.5 ProSci Recent Development
11.3 GeneTex
11.3.1 GeneTex Company Details
11.3.2 GeneTex Business Overview
11.3.3 GeneTex Anti-GFP Antibody Introduction
11.3.4 GeneTex Revenue in Anti-GFP Antibody Business (2020-2025)
11.3.5 GeneTex Recent Development
11.4 Bioss
11.4.1 Bioss Company Details
11.4.2 Bioss Business Overview
11.4.3 Bioss Anti-GFP Antibody Introduction
11.4.4 Bioss Revenue in Anti-GFP Antibody Business (2020-2025)
11.4.5 Bioss Recent Development
11.5 Rockland Immunochemicals
11.5.1 Rockland Immunochemicals Company Details
11.5.2 Rockland Immunochemicals Business Overview
11.5.3 Rockland Immunochemicals Anti-GFP Antibody Introduction
11.5.4 Rockland Immunochemicals Revenue in Anti-GFP Antibody Business (2020-2025)
11.5.5 Rockland Immunochemicals Recent Development
11.6 Cell Signaling Technology
11.6.1 Cell Signaling Technology Company Details
11.6.2 Cell Signaling Technology Business Overview
11.6.3 Cell Signaling Technology Anti-GFP Antibody Introduction
11.6.4 Cell Signaling Technology Revenue in Anti-GFP Antibody Business (2020-2025)
11.6.5 Cell Signaling Technology Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Details
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Anti-GFP Antibody Introduction
11.7.4 Novus Biologicals Revenue in Anti-GFP Antibody Business (2020-2025)
11.7.5 Novus Biologicals Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Anti-GFP Antibody Introduction
11.8.4 Thermo Fisher Scientific Revenue in Anti-GFP Antibody Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Biorbyt
11.9.1 Biorbyt Company Details
11.9.2 Biorbyt Business Overview
11.9.3 Biorbyt Anti-GFP Antibody Introduction
11.9.4 Biorbyt Revenue in Anti-GFP Antibody Business (2020-2025)
11.9.5 Biorbyt Recent Development
11.10 R&D Systems
11.10.1 R&D Systems Company Details
11.10.2 R&D Systems Business Overview
11.10.3 R&D Systems Anti-GFP Antibody Introduction
11.10.4 R&D Systems Revenue in Anti-GFP Antibody Business (2020-2025)
11.10.5 R&D Systems Recent Development
11.11 BioLegend
11.11.1 BioLegend Company Details
11.11.2 BioLegend Business Overview
11.11.3 BioLegend Anti-GFP Antibody Introduction
11.11.4 BioLegend Revenue in Anti-GFP Antibody Business (2020-2025)
11.11.5 BioLegend Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Details
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies Anti-GFP Antibody Introduction
11.12.4 OriGene Technologies Revenue in Anti-GFP Antibody Business (2020-2025)
11.12.5 OriGene Technologies Recent Development
11.13 ImmuQuest
11.13.1 ImmuQuest Company Details
11.13.2 ImmuQuest Business Overview
11.13.3 ImmuQuest Anti-GFP Antibody Introduction
11.13.4 ImmuQuest Revenue in Anti-GFP Antibody Business (2020-2025)
11.13.5 ImmuQuest Recent Development
11.14 Abbexa
11.14.1 Abbexa Company Details
11.14.2 Abbexa Business Overview
11.14.3 Abbexa Anti-GFP Antibody Introduction
11.14.4 Abbexa Revenue in Anti-GFP Antibody Business (2020-2025)
11.14.5 Abbexa Recent Development
11.15 EpiGentek
11.15.1 EpiGentek Company Details
11.15.2 EpiGentek Business Overview
11.15.3 EpiGentek Anti-GFP Antibody Introduction
11.15.4 EpiGentek Revenue in Anti-GFP Antibody Business (2020-2025)
11.15.5 EpiGentek Recent Development
11.16 Synaptic Systems
11.16.1 Synaptic Systems Company Details
11.16.2 Synaptic Systems Business Overview
11.16.3 Synaptic Systems Anti-GFP Antibody Introduction
11.16.4 Synaptic Systems Revenue in Anti-GFP Antibody Business (2020-2025)
11.16.5 Synaptic Systems Recent Development
11.17 Santa Cruz Biotechnology
11.17.1 Santa Cruz Biotechnology Company Details
11.17.2 Santa Cruz Biotechnology Business Overview
11.17.3 Santa Cruz Biotechnology Anti-GFP Antibody Introduction
11.17.4 Santa Cruz Biotechnology Revenue in Anti-GFP Antibody Business (2020-2025)
11.17.5 Santa Cruz Biotechnology Recent Development
11.18 Proteintech Group
11.18.1 Proteintech Group Company Details
11.18.2 Proteintech Group Business Overview
11.18.3 Proteintech Group Anti-GFP Antibody Introduction
11.18.4 Proteintech Group Revenue in Anti-GFP Antibody Business (2020-2025)
11.18.5 Proteintech Group Recent Development
11.19 IBL
11.19.1 IBL Company Details
11.19.2 IBL Business Overview
11.19.3 IBL Anti-GFP Antibody Introduction
11.19.4 IBL Revenue in Anti-GFP Antibody Business (2020-2025)
11.19.5 IBL Recent Development
11.20 LSBio
11.20.1 LSBio Company Details
11.20.2 LSBio Business Overview
11.20.3 LSBio Anti-GFP Antibody Introduction
11.20.4 LSBio Revenue in Anti-GFP Antibody Business (2020-2025)
11.20.5 LSBio Recent Development
11.21 Signalway Antibody
11.21.1 Signalway Antibody Company Details
11.21.2 Signalway Antibody Business Overview
11.21.3 Signalway Antibody Anti-GFP Antibody Introduction
11.21.4 Signalway Antibody Revenue in Anti-GFP Antibody Business (2020-2025)
11.21.5 Signalway Antibody Recent Development
11.22 Agrisera
11.22.1 Agrisera Company Details
11.22.2 Agrisera Business Overview
11.22.3 Agrisera Anti-GFP Antibody Introduction
11.22.4 Agrisera Revenue in Anti-GFP Antibody Business (2020-2025)
11.22.5 Agrisera Recent Development
11.23 Bio X Cell
11.23.1 Bio X Cell Company Details
11.23.2 Bio X Cell Business Overview
11.23.3 Bio X Cell Anti-GFP Antibody Introduction
11.23.4 Bio X Cell Revenue in Anti-GFP Antibody Business (2020-2025)
11.23.5 Bio X Cell Recent Development
11.24 StressMarq Biosciences
11.24.1 StressMarq Biosciences Company Details
11.24.2 StressMarq Biosciences Business Overview
11.24.3 StressMarq Biosciences Anti-GFP Antibody Introduction
11.24.4 StressMarq Biosciences Revenue in Anti-GFP Antibody Business (2020-2025)
11.24.5 StressMarq Biosciences Recent Development
11.25 RayBiotech
11.25.1 RayBiotech Company Details
11.25.2 RayBiotech Business Overview
11.25.3 RayBiotech Anti-GFP Antibody Introduction
11.25.4 RayBiotech Revenue in Anti-GFP Antibody Business (2020-2025)
11.25.5 RayBiotech Recent Development
11.26 Abnova
11.26.1 Abnova Company Details
11.26.2 Abnova Business Overview
11.26.3 Abnova Anti-GFP Antibody Introduction
11.26.4 Abnova Revenue in Anti-GFP Antibody Business (2020-2025)
11.26.5 Abnova Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Anti-GFP Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global Anti-GFP Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti-GFP Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-GFP Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti-GFP Antibody Market Share by Region (2020-2025)
Table 8. Global Anti-GFP Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti-GFP Antibody Market Share by Region (2026-2031)
Table 10. Anti-GFP Antibody Market Trends
Table 11. Anti-GFP Antibody Market Drivers
Table 12. Anti-GFP Antibody Market Challenges
Table 13. Anti-GFP Antibody Market Restraints
Table 14. Global Anti-GFP Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti-GFP Antibody Market Share by Players (2020-2025)
Table 16. Global Top Anti-GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-GFP Antibody as of 2024)
Table 17. Ranking of Global Top Anti-GFP Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-GFP Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti-GFP Antibody, Headquarters and Area Served
Table 20. Global Key Players of Anti-GFP Antibody, Product and Application
Table 21. Global Key Players of Anti-GFP Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-GFP Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti-GFP Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global Anti-GFP Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-GFP Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global Anti-GFP Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Anti-GFP Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global Anti-GFP Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Anti-GFP Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti-GFP Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti-GFP Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti-GFP Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti-GFP Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti-GFP Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti-GFP Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. FUJIFILM Wako Chemicals Company Details
Table 47. FUJIFILM Wako Chemicals Business Overview
Table 48. FUJIFILM Wako Chemicals Anti-GFP Antibody Product
Table 49. FUJIFILM Wako Chemicals Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 50. FUJIFILM Wako Chemicals Recent Development
Table 51. ProSci Company Details
Table 52. ProSci Business Overview
Table 53. ProSci Anti-GFP Antibody Product
Table 54. ProSci Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 55. ProSci Recent Development
Table 56. GeneTex Company Details
Table 57. GeneTex Business Overview
Table 58. GeneTex Anti-GFP Antibody Product
Table 59. GeneTex Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 60. GeneTex Recent Development
Table 61. Bioss Company Details
Table 62. Bioss Business Overview
Table 63. Bioss Anti-GFP Antibody Product
Table 64. Bioss Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 65. Bioss Recent Development
Table 66. Rockland Immunochemicals Company Details
Table 67. Rockland Immunochemicals Business Overview
Table 68. Rockland Immunochemicals Anti-GFP Antibody Product
Table 69. Rockland Immunochemicals Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 70. Rockland Immunochemicals Recent Development
Table 71. Cell Signaling Technology Company Details
Table 72. Cell Signaling Technology Business Overview
Table 73. Cell Signaling Technology Anti-GFP Antibody Product
Table 74. Cell Signaling Technology Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 75. Cell Signaling Technology Recent Development
Table 76. Novus Biologicals Company Details
Table 77. Novus Biologicals Business Overview
Table 78. Novus Biologicals Anti-GFP Antibody Product
Table 79. Novus Biologicals Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 80. Novus Biologicals Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Anti-GFP Antibody Product
Table 84. Thermo Fisher Scientific Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Biorbyt Company Details
Table 87. Biorbyt Business Overview
Table 88. Biorbyt Anti-GFP Antibody Product
Table 89. Biorbyt Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 90. Biorbyt Recent Development
Table 91. R&D Systems Company Details
Table 92. R&D Systems Business Overview
Table 93. R&D Systems Anti-GFP Antibody Product
Table 94. R&D Systems Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 95. R&D Systems Recent Development
Table 96. BioLegend Company Details
Table 97. BioLegend Business Overview
Table 98. BioLegend Anti-GFP Antibody Product
Table 99. BioLegend Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 100. BioLegend Recent Development
Table 101. OriGene Technologies Company Details
Table 102. OriGene Technologies Business Overview
Table 103. OriGene Technologies Anti-GFP Antibody Product
Table 104. OriGene Technologies Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 105. OriGene Technologies Recent Development
Table 106. ImmuQuest Company Details
Table 107. ImmuQuest Business Overview
Table 108. ImmuQuest Anti-GFP Antibody Product
Table 109. ImmuQuest Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 110. ImmuQuest Recent Development
Table 111. Abbexa Company Details
Table 112. Abbexa Business Overview
Table 113. Abbexa Anti-GFP Antibody Product
Table 114. Abbexa Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 115. Abbexa Recent Development
Table 116. EpiGentek Company Details
Table 117. EpiGentek Business Overview
Table 118. EpiGentek Anti-GFP Antibody Product
Table 119. EpiGentek Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 120. EpiGentek Recent Development
Table 121. Synaptic Systems Company Details
Table 122. Synaptic Systems Business Overview
Table 123. Synaptic Systems Anti-GFP Antibody Product
Table 124. Synaptic Systems Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 125. Synaptic Systems Recent Development
Table 126. Santa Cruz Biotechnology Company Details
Table 127. Santa Cruz Biotechnology Business Overview
Table 128. Santa Cruz Biotechnology Anti-GFP Antibody Product
Table 129. Santa Cruz Biotechnology Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 130. Santa Cruz Biotechnology Recent Development
Table 131. Proteintech Group Company Details
Table 132. Proteintech Group Business Overview
Table 133. Proteintech Group Anti-GFP Antibody Product
Table 134. Proteintech Group Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 135. Proteintech Group Recent Development
Table 136. IBL Company Details
Table 137. IBL Business Overview
Table 138. IBL Anti-GFP Antibody Product
Table 139. IBL Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 140. IBL Recent Development
Table 141. LSBio Company Details
Table 142. LSBio Business Overview
Table 143. LSBio Anti-GFP Antibody Product
Table 144. LSBio Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 145. LSBio Recent Development
Table 146. Signalway Antibody Company Details
Table 147. Signalway Antibody Business Overview
Table 148. Signalway Antibody Anti-GFP Antibody Product
Table 149. Signalway Antibody Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 150. Signalway Antibody Recent Development
Table 151. Agrisera Company Details
Table 152. Agrisera Business Overview
Table 153. Agrisera Anti-GFP Antibody Product
Table 154. Agrisera Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 155. Agrisera Recent Development
Table 156. Bio X Cell Company Details
Table 157. Bio X Cell Business Overview
Table 158. Bio X Cell Anti-GFP Antibody Product
Table 159. Bio X Cell Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 160. Bio X Cell Recent Development
Table 161. StressMarq Biosciences Company Details
Table 162. StressMarq Biosciences Business Overview
Table 163. StressMarq Biosciences Anti-GFP Antibody Product
Table 164. StressMarq Biosciences Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 165. StressMarq Biosciences Recent Development
Table 166. RayBiotech Company Details
Table 167. RayBiotech Business Overview
Table 168. RayBiotech Anti-GFP Antibody Product
Table 169. RayBiotech Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 170. RayBiotech Recent Development
Table 171. Abnova Company Details
Table 172. Abnova Business Overview
Table 173. Abnova Anti-GFP Antibody Product
Table 174. Abnova Revenue in Anti-GFP Antibody Business (2020-2025) & (US$ Million)
Table 175. Abnova Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
Table 179. Authors List of This Report


List of Figures
Figure 1. Anti-GFP Antibody Picture
Figure 2. Global Anti-GFP Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-GFP Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Features
Figure 5. Polyclonal Antibody Features
Figure 6. Global Anti-GFP Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-GFP Antibody Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-GFP Antibody Report Years Considered
Figure 13. Global Anti-GFP Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Anti-GFP Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-GFP Antibody Market Share by Region: 2024 VS 2031
Figure 16. Global Anti-GFP Antibody Market Share by Players in 2024
Figure 17. Global Top Anti-GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-GFP Antibody as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Anti-GFP Antibody Revenue in 2024
Figure 19. North America Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Anti-GFP Antibody Market Share by Country (2020-2031)
Figure 21. United States Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-GFP Antibody Market Share by Country (2020-2031)
Figure 25. Germany Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-GFP Antibody Market Share by Region (2020-2031)
Figure 33. China Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-GFP Antibody Market Share by Country (2020-2031)
Figure 41. Mexico Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-GFP Antibody Market Share by Country (2020-2031)
Figure 45. Turkey Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Anti-GFP Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. FUJIFILM Wako Chemicals Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 49. ProSci Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 50. GeneTex Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 51. Bioss Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 52. Rockland Immunochemicals Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 53. Cell Signaling Technology Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 54. Novus Biologicals Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 56. Biorbyt Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 57. R&D Systems Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 58. BioLegend Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 59. OriGene Technologies Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 60. ImmuQuest Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 61. Abbexa Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 62. EpiGentek Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 63. Synaptic Systems Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 64. Santa Cruz Biotechnology Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 65. Proteintech Group Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 66. IBL Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 67. LSBio Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 68. Signalway Antibody Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 69. Agrisera Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 70. Bio X Cell Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 71. StressMarq Biosciences Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 72. RayBiotech Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 73. Abnova Revenue Growth Rate in Anti-GFP Antibody Business (2020-2025)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit